EUVIMEDEUVIMED entdecken
Open Access

A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer

Yun Lin, Rendong Zhang, Hongchao Pan, Yaochen Li

Medical Science Monitor · 2023

DOI: 10.12659/msm.938660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Monitor, 2023. Verfasst von Yun Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China (mainland). Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Cervical cancer is one of the most common malignances among women globally. This study aimed to construct a novel immune-related signature to predict the prognosis and immune infiltration of cervical cancer. MATERIAL AND METHODS Transcriptomic profiles and corresponding clinical information of cervical cancer patients were obtained from The Cancer Genome Atlas (TCGA) database and GEO database. The hub immune-related genes were screened and selected using Cox regression analysis and LASSO regression analysis. A novel signature was established based on the expression levels and corresponding coefficients of the selected hub immune-related genes. Kaplan-Meier survival curve and ROC curve illustrated the prognostic value of this novel signature in cervical cancer. The predictive accuracy and stability of this novel signature were confirmed in the validation cohort, internal testing set and external testing set. Then, a nomogram was constructed to predict individual survival probability of cervical cancer patient. The association between the risk scores of novel signature and immune infiltration was investigated through single-sample gene set enrichment analysis (ssGSEA). RESULTS Ten hub immune-related genes (TFRC, SPP1, CAMP, CSF2, TUBB3, ZAP70, CHIT1, LEPR, DLL4, and DES) were selected to construct a novel signature. The risk score of this novel signature could be an independent prognostic factor in cervical cancer, which divided patients into high-risk and low-risk groups. The patients in high-risk groups showed significantly worse overall survival rates than those in low-risk groups in all training and validation cohorts (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsHumansFemalePrognosisNomogramsRisk FactorsDatabases, Factual

Autor:innen und Institutionen

  • Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China (mainland).
  • Breast Center, Surgical Oncology Session No. 1, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China (mainland).

Zitieren

APA

Lin, Y., Zhang, R., Pan, H., & Li, Y. (2023). A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer. Medical Science Monitor. https://doi.org/10.12659/msm.938660

Vancouver

Lin Y, Zhang R, Pan H, Li Y. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer. Medical Science Monitor. 2023. doi:10.12659/msm.938660

BibTeX
@article{Lin2023,
  author = {Lin, Yun and Zhang, Rendong and Pan, Hongchao and Li, Yaochen},
  title = {A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer},
  journal = {Medical Science Monitor},
  year = {2023},
  doi = {10.12659/msm.938660}
}
Kostenlos starten →